I also have huge respect for the Long Termers , the initial Positive Scientific Results from the previous trial was totally over-shadowed by the poor palatability issue,
PAA Management then began rectifying the issue, they worked with BRI, who reformulated MPL to not only be orally ingestable,palatable but increased efficacy through micronisation.
PAA could have utilised Pill Pockets,,that's what lesser companies have done to hide the taste of medication.
But they didn't they committed to the original strategy of the dogs wanting to consume the pill,, ( for those who have had dogs trying to push a pill down the back of the throat is fairly brutal) plus the dogs we are treating are possibly feeling the effects of Lymphoma.
The SP took a kick to the jewels and dropped like " a Biotech that missed an End Point"
The fortitude required to stick with the company is now beginning to be rewarded again,,, Thank you to all those that have shared information surrounding this investment..
I look forward with genuine excitement on how far this company can actually travel ... sure MPL has to do, what it says it does on the can and that time is not very far away ,,90 to 120 days data in front of Elanco..... if an agreement could be reached before Christmas or a strong indication given,,,well ,,,now that would be a fantastic present....
- Forums
- ASX - By Stock
- Long term considerations
I also have huge respect for the Long Termers , the initial...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.015(7.50%) |
Mkt cap ! $90.96M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 18.5¢ | $115.7K | 598.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 593392 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 4355 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 593392 | 0.185 |
8 | 337474 | 0.180 |
5 | 145797 | 0.175 |
4 | 130250 | 0.170 |
1 | 60000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 4355 | 1 |
0.200 | 77907 | 4 |
0.205 | 109808 | 2 |
0.210 | 147252 | 4 |
0.215 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online